CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope A Skowera, RJ Ellis, R Varela-Calviño, S Arif, GC Huang, C Van-Krinks, ... The Journal of clinical investigation 118 (10), 3390-3402, 2008 | 455 | 2008 |
Protein coding assignment of avian reovirus strain S1133 R Varela, J Benavente Journal of virology 68 (10), 6775-6777, 1994 | 159 | 1994 |
Protein architecture of avian reovirus S1133 and identification of the cell attachment protein J Martínez-Costas, A Grande, R Varela, C García-Martínez, J Benavente Journal of virology 71 (1), 59-64, 1997 | 135 | 1997 |
Cellular immune activation in Gulf War veterans A Skowera, M Hotopf, E Sawicka, R Varela-Calvino, C Unwin, V Nikolaou, ... Journal of clinical immunology 24, 66-73, 2004 | 86 | 2004 |
Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes R Varela-Calvino, R Ellis, G Sgarbi, CM Dayan, M Peakman Diabetes 51 (6), 1745-1753, 2002 | 62 | 2002 |
Intracellular posttranslational modifications of S1133 avian reovirus proteins R Varela, J Martínez-Costas, M Mallo, J Benavente Journal of virology 70 (5), 2974-2981, 1996 | 61 | 1996 |
Enteroviruses and type 1 diabetes R Varela‐Calvino, M Peakman Diabetes/metabolism research and reviews 19 (6), 431-441, 2003 | 51 | 2003 |
Endogenous enzymatic activities of the avian reovirus S1133: identification of the viral capping enzyme J Martinez-Costas, R Varela, J Benavente Virology 206 (2), 1017-1026, 1995 | 48 | 1995 |
T-Cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4 R Varela-Calvino, G Sgarbi, S Arif, M Peakman Virology 274 (1), 56-64, 2000 | 47 | 2000 |
Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2. 1 and located in the PEVKEK region of the P2C nonstructural protein R Varela-Calvino, A Skowera, S Arif, M Peakman Journal of virology 78 (24), 13399-13408, 2004 | 34 | 2004 |
CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis OJ Cordero, R Varela-Calviño, T López-González, C Calviño-Sampedro, ... Plos one 10 (7), e0131992, 2015 | 32 | 2015 |
Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells P Sauter, PE Lobert, B Lucas, R Varela-Calvino, G Alm, P Wattre, D Hober Virus research 125 (2), 183-190, 2007 | 27 | 2007 |
Autoantibodies to glial fibrillary acid protein and S100β in diabetic patients I Gomez‐Tourino, F Camiña‐Darriba, I Otero‐Romero, MA Rodríguez, ... Diabetic Medicine 27 (2), 246-248, 2010 | 26 | 2010 |
Oral hygiene might prevent cancer OJ Cordero, R Varela-Calviño Heliyon 4 (10), 2018 | 24 | 2018 |
Human peripheral blood mononuclear cell in vitro system to test the efficacy of food bioactive compounds: Effects of polyunsaturated fatty acids and their relation with BMI M Cifre, R Díaz‐Rúa, R Varela‐Calviño, B Reynés, J Pericás‐Beltrán, ... Molecular Nutrition & Food Research 61 (4), 1600353, 2017 | 21 | 2017 |
HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides RJ Ellis, R Varela‐Calvino, TIM Tree, M Peakman Immunology 116 (3), 337-346, 2005 | 21 | 2005 |
Dry powder comprised of isoniazid-loaded nanoparticles of hyaluronic acid in conjugation with mannose-anchored chitosan for macrophage-targeted pulmonary administration in … M Mukhtar, N Csaba, S Robla, R Varela-Calviño, A Nagy, K Burian, ... Pharmaceutics 14 (8), 1543, 2022 | 20 | 2022 |
A chitosan-based nanosystem as pneumococcal vaccine delivery platform S Robla, M Prasanna, R Varela-Calviño, C Grandjean, N Csaba Drug Delivery and Translational Research 11, 581-597, 2021 | 19 | 2021 |
Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest OJ Cordero, R Varela-Calviño, T López-González, M Grujic, Z Juranic, ... Clinical Biochemistry 50 (16-17), 903-910, 2017 | 18 | 2017 |
T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vβ usage without superantigenic activity R Varela-Calvino, G Sgarbi, LR Wedderburn, CM Dayan, J Tremble, ... The Journal of Immunology 167 (6), 3513-3520, 2001 | 18 | 2001 |